Log in

Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis

  • Review Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The association between overactive bladder (OAB) syndrome and sexual dysfunction is well documented. Intra-detrusor onabotulinumtoxinA (Botox) has proven to be effective treatment for OAB syndrome. Our aim was to examine the impact of intravesical Botox injection on sexual function in patients with OAB, by systematically reviewing the literature.

Methods

We reviewed the literature for studies that reported a change in sexual function after Botox treatment in patients suffering from OAB. This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement using pre-agreed keywords, from database inception to December 2020. Statistical analyses were performed using Review Manager (RevMan; v.5.4).

Results

Initial results yielded 455 citations. Seven articles met our inclusion criteria. One article was double-reported, leaving 6 studies in the systematic review. Three observational before-and-after studies used the Female Sexual Function Index (FSFI) with sufficient information, and therefore were included in our meta-analysis. The pooled number of participants in all studies was 119 patients. In the meta-analysis, there was significant improvement in the following domains of the FSFI after Botox injection; desire (mean difference (MD) −0.51, p = 0.02), arousal (MD −0.86, p = 0.02), lubrication (MD −0.57, p = 0.03), orgasm (MD −0.65, p = 0.0003) and satisfaction (MD −0.46, p = 0.05). Pain was the only domain that did not show improvement (MD −0.07, p = 0.79). The total FSFI score was reported in 88 patients (two studies) showing significant improvement (MD −0.77, p = 0.006).

Conclusions

We report a systematic review of the effect of Botox treatment on sexual function in patients with OAB. Although studies are small, the results indicate a positive effect in patients with OAB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Abrams P, Andersson KE, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–40. https://doi.org/10.1002/nau.20870.

    Article  CAS  PubMed  Google Scholar 

  2. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14; discussion 1314–5. https://doi.org/10.1016/j.eururo.2006.09.019.

    Article  PubMed  Google Scholar 

  3. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 Suppl):S580–90.

    CAS  PubMed  Google Scholar 

  4. Perry S, McGrother CW, Turner K, Leicestershire MRC Incontinence Study Group. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11(Pt 3):463–82. https://doi.org/10.1348/135910705X60742.

    Article  PubMed  Google Scholar 

  5. Sen I, Onaran M, Tan MO, Acar C, Camtosun A, Sozen S, Bozkirli I. Evaluation of sexual function in women with overactive bladder syndrome. Urol Int. 2007;78(2):112–5. https://doi.org/10.1159/000098066.

    Article  PubMed  Google Scholar 

  6. Patel AS, O'Leary ML, Stein RJ, Leng WW, Chancellor MB, Patel SG, Borello-France D. The relationship between overactive bladder and sexual activity in women. Int Braz J Urol. 2006;32(1):77–87. https://doi.org/10.1590/s1677-55382006000100014.

    Article  PubMed  Google Scholar 

  7. Zahariou A, Karamouti M, Tyligada E, Papaioannou P. Sexual function in women with overactive bladder. Female Pelvic Med Reconstr Surg. 2010;16(1):31–6. https://doi.org/10.1097/SPV.0b013e3181bf51eb.

    Article  PubMed  Google Scholar 

  8. Jha S, Ammenbal M, Metwally M. Impact of incontinence surgery on sexual function: a systematic review and meta-analysis. J Sex Med. 2012;9(1):34–43. https://doi.org/10.1111/j.1743-6109.2011.02366.x.

    Article  PubMed  Google Scholar 

  9. López Ramos H, Torres Castellanos L, Ponce Esparza I, Jaramillo A, Rodríguez A, Moreno Bencardino C. Management of overactive bladder with onabotulinumtoxinA: systematic review and meta-analysis. Urology. 2017;100:53–8. https://doi.org/10.1016/j.urology.2016.10.026.

    Article  PubMed  Google Scholar 

  10. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. https://doi.org/10.1136/bmj.b2535.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

    Article  PubMed  Google Scholar 

  13. Giannantoni A, Gubbiotti M, et al. Effects of Onabotulinum toxin a intradetrusor injections on urinary symptoms and sexual life in women affected by multiple sclerosis: a prospective controlled study. J Neurol Neurophysiol. 2017;8(3):1000427. https://doi.org/10.4172/2155-9562.1000427.

    Article  CAS  Google Scholar 

  14. Giannantoni A, Proietti S, Giusti G, et al. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results. World J Urol. 2015;33(12):2095–101. https://doi.org/10.1007/s00345-015-1578-4.

    Article  CAS  PubMed  Google Scholar 

  15. Nitti VW, Dmochowski R, Herschorn S, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013;189(6):2186–93. https://doi.org/10.1016/j.juro.2012.12.022.

    Article  CAS  PubMed  Google Scholar 

  16. Chapple C, Sievert K-D, MacDiarmid S, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64(2):249–56. https://doi.org/10.1016/j.eururo.2013.04.001.

    Article  CAS  PubMed  Google Scholar 

  17. Fowler CJ, Auerbach S, Ginsberg D, et al. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial. Eur Urol. 2012;62(1):148–57. https://doi.org/10.1016/j.eururo.2012.03.005.

    Article  CAS  PubMed  Google Scholar 

  18. Balzarro M, Rubilotta E, Braga A, et al. OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome. Eur J Obstet Gynecol Reprod Biol. 2018;225:228–31. https://doi.org/10.1016/j.ejogrb.2018.05.002.

    Article  CAS  PubMed  Google Scholar 

  19. Miotla P, Cartwright R, Skorupska K, et al. Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB. Neurourol Urodyn. 2017;36(6):1564–9. https://doi.org/10.1002/nau.23148.

    Article  CAS  PubMed  Google Scholar 

  20. Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. https://doi.org/10.1080/009262300278597.

    Article  CAS  PubMed  Google Scholar 

  21. Balzarro M, Rubilotta E, Mancini V, et al. Impact of overactive bladder-wet syndrome on female sexual function: a systematic review and meta-analysis. Sex Med Rev. 2019;7(4):565–74. https://doi.org/10.1016/j.sxmr.2019.05.002.

    Article  PubMed  Google Scholar 

  22. Levy G, Lowenstein L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sex Med. 2020;8(1):1–7. https://doi.org/10.1016/j.esxm.2019.08.013.

    Article  PubMed  Google Scholar 

  23. Zachariou A, Mamoulakis C, Filiponi M, et al. The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol. 2018;18(1):61. https://doi.org/10.1186/s12894-018-0377-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Del Rosso A, Pace G, Di Pierro ED, Masciovecchio S, Galatioto GP, Vicentini C. Impact of overactive bladder on sexual function in women. Urologia. 2011;78(3):200–2. https://doi.org/10.5301/RU.2011.8547.

    Article  PubMed  Google Scholar 

  25. Cakir SS, Degirmentepe RB, Atalay HA, et al. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study. Int Urol Nephrol. 2019;51(1):27–32. https://doi.org/10.1007/s11255-018-2030-7.

    Article  CAS  PubMed  Google Scholar 

  26. Zachariou A, Filiponi M. The effect of extended release tolterodine used for overactive bladder treatment on female sexual function. Int Braz J Urol. 2017;43(4):713–20. https://doi.org/10.1590/S1677-5538.IBJU.2016.0303.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Autiero SW, Hallas N, Betts CD, Ockrim JL. The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK. BJU Int. 2015;116(6):945–54. https://doi.org/10.1111/bju.12972.

    Article  CAS  PubMed  Google Scholar 

  28. Khunda A, McCormick C, Ballard P. Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature. Int Urogynecol J. 2019;30(3):339–52. https://doi.org/10.1007/s00192-018-3841-x.

    Article  PubMed  Google Scholar 

  29. Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–16. https://doi.org/10.1002/nau.22251.

    Article  CAS  PubMed  Google Scholar 

  30. Kershaw V, Khunda A, McCormick C, Ballard P. The effect of percutaneous tibial nerve stimulation (PTNS) on sexual function: a systematic review and meta-analysis. Int Urogynecol J. 2019;30(10):1619–27. https://doi.org/10.1007/s00192-019-04027-3.

    Article  PubMed  Google Scholar 

  31. Weinberger JM, Houman J, Caron AT, et al. Female sexual dysfunction and the placebo effect: a meta-analysis. Obstet Gynecol. 2018;132(2):453–8. https://doi.org/10.1097/AOG.0000000000002733.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the help and support provided by Heba Shawer in the editing and revision of this review and for Mrs. Carol McCormick for help with the literature search.

Funding

No external funding was used for this systematic review and meta-analysis.

Author information

Authors and Affiliations

Authors

Contributions

Sami Shawer: project development, data collection and analysis, manuscript writing; Aethele Khunda: project development, data collection, revision of the manuscript, overall supervision, and final approval; Gareth J. Waring: project development, revision of the manuscript and supervision; Paul Ballard: supervision of the project and final approval.

Corresponding author

Correspondence to Sami Shawer.

Ethics declarations

Conflicts of interest

Sami Shawer: no conflicts of interest; Aethele Khunda: in the last 5 years, received educational grants from Medtronic, Olympus, Axonic and speaker fees from Astellas (I also received travel and accommodation expenses from conference organisers when invited as a speaker); Gareth J. Waring: no conflicts of interest; Paul Ballard: in the last 5 years, received an educational grant from Olympus.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shawer, S., Khunda, A., Waring, G.J. et al. Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J 33, 235–243 (2022). https://doi.org/10.1007/s00192-021-05072-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-021-05072-7

Keywords

Navigation